Type of Renal Replacement Therapy (Hemodialysis versus Peritoneal Dialysis) Does Not Affect Cytokine Gene Expression or Clinical Parameters of Renal Transplant Candidates
Table 1
Subject characteristics.
HD patients ()
PD patients ()
Age (years, mean ± SD, median [IQR])
48 ± 12 53.5 [19–72]
42 ± 14 40 [16–68]
0.084
Gender (female/male)
39 (59%)/27 (41%)
14 (67%)/7 (33%)
0.72
Time of dialysis (months, mean ± SD, median [IQR])
33 ± 42 24.5 [13–36]
15 ± 10 15 [6–22]
0.017
BMI (kg/m2)
24.6 ± 3.6
24.8 ± 3.7
0.80
Primary disease
Diabetic nephropathy
4 (6%)
5 (24%)
Chronic glomerulonephritis
22 (33%)
12 (57%)
Hypertensive nephropathy
7 (11%)
1 (5%)
Polycystic renal disease
9 (14%)
1 (5%)
Chronic interstitial nephritis
16 (24%)
0
Unknown
8 (12%)
2 (9%)
PD: continuous ambulatory peritoneal dialysis; from -tests; from Mann-Whitney -test.
